Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

CHYM vs AFRM vs SOFI vs DAVE

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CHYM
Chime Financial, Inc. Class A Common Stock

Banks - Regional

Financial ServicesNASDAQ • US
Market Cap$7.61B
5Y Perf.-44.9%
AFRM
Affirm Holdings, Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$22.44B
5Y Perf.-2.6%
SOFI
SoFi Technologies, Inc.

Financial - Credit Services

Financial ServicesNASDAQ • US
Market Cap$20.40B
5Y Perf.-12.1%
DAVE
Dave Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$3.35B
5Y Perf.-7.1%

CHYM vs AFRM vs SOFI vs DAVE — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CHYM logoCHYM
AFRM logoAFRM
SOFI logoSOFI
DAVE logoDAVE
IndustryBanks - RegionalSoftware - InfrastructureFinancial - Credit ServicesSoftware - Application
Market Cap$7.61B$22.44B$20.40B$3.35B
Revenue (TTM)$2.19B$3.20B$4.77B$552M
Net Income (TTM)$-969M$382M$481M$225M
Gross Margin85.9%62.6%75.1%81.5%
Operating Margin-47.6%10.2%11.0%4.9%
Forward P/E112.9x62.5x26.5x19.1x
Total Debt$135M$7.85B$1.82B$75M
Cash & Equiv.$466M$1.35B$4.93B$81M

CHYM vs AFRM vs SOFI vs DAVELong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CHYM
AFRM
SOFI
DAVE
StockJun 25May 26Return
Chime Financial, In… (CHYM)10055.1-44.9%
Affirm Holdings, In… (AFRM)10097.4-2.6%
SoFi Technologies, … (SOFI)10087.9-12.1%
Dave Inc. (DAVE)10092.9-7.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: CHYM vs AFRM vs SOFI vs DAVE

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: DAVE leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Chime Financial, Inc. Class A Common Stock is the stronger pick specifically for capital preservation and lower volatility. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CHYM
Chime Financial, Inc. Class A Common Stock
The Banking Pick

CHYM is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.

  • beta 2.50
  • Lower volatility, beta 2.50, Low D/E 9.6%, current ratio 4.53x
  • Beta 2.50, current ratio 4.53x
  • Beta 2.50 vs AFRM's 2.72, lower leverage
Best for: income & stability and sleep-well-at-night
AFRM
Affirm Holdings, Inc.
The Growth Angle

AFRM plays a supporting role in this comparison — it may shine differently against other peers.

Best for: technology exposure
SOFI
SoFi Technologies, Inc.
The Banking Pick

SOFI is the clearest fit if your priority is long-term compounding.

  • 52.7% 10Y total return vs AFRM's -30.7%
Best for: long-term compounding
DAVE
Dave Inc.
The Growth Play

DAVE carries the broadest edge in this set and is the clearest fit for growth exposure.

  • Rev growth 47.5%, EPS growth 222.9%, 3Y rev CAGR 35.7%
  • 47.5% revenue growth vs SOFI's 28.8%
  • Lower P/E (19.1x vs 62.5x)
  • 40.8% margin vs CHYM's -46.2%
Best for: growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthDAVE logoDAVE47.5% revenue growth vs SOFI's 28.8%
ValueDAVE logoDAVELower P/E (19.1x vs 62.5x)
Quality / MarginsDAVE logoDAVE40.8% margin vs CHYM's -46.2%
Stability / SafetyCHYM logoCHYMBeta 2.50 vs AFRM's 2.72, lower leverage
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)DAVE logoDAVE+131.2% vs CHYM's -48.8%
Efficiency (ROA)DAVE logoDAVE49.6% ROA vs CHYM's -49.8%, ROIC 11.1% vs -60.2%

CHYM vs AFRM vs SOFI vs DAVE — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CHYMChime Financial, Inc. Class A Common Stock
FY 2025
Payments Revenue
100.0%$1.5B
AFRMAffirm Holdings, Inc.
FY 2025
Merchant Network
79.2%$883M
Virtual Card Network
20.8%$231M
SOFISoFi Technologies, Inc.
FY 2025
Lending Segment
48.1%$1.8B
Financial Services Segment
40.1%$1.5B
Technology Platform Segment
11.7%$450M
DAVEDave Inc.
FY 2025
Subscriptions
99.1%$37M
Other
0.9%$349,000

CHYM vs AFRM vs SOFI vs DAVE — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLDAVELAGGINGSOFI

Income & Cash Flow (Last 12 Months)

DAVE leads this category, winning 4 of 6 comparable metrics.

SOFI is the larger business by revenue, generating $4.8B annually — 8.6x DAVE's $552M. DAVE is the more profitable business, keeping 40.8% of every revenue dollar as net income compared to CHYM's -46.2%. On growth, DAVE holds the edge at +36.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …SOFI logoSOFISoFi Technologies…DAVE logoDAVEDave Inc.
RevenueTrailing 12 months$2.2B$3.2B$4.8B$552M
EBITDAEarnings before interest/tax-$976M$533M$760M$33M
Net IncomeAfter-tax profit-$969M$382M$481M$225M
Free Cash FlowCash after capex$144M$787M-$2.6B$327M
Gross MarginGross profit ÷ Revenue+85.9%+62.6%+75.1%+81.5%
Operating MarginEBIT ÷ Revenue-47.6%+10.2%+11.0%+4.9%
Net MarginNet income ÷ Revenue-46.2%+11.9%+10.1%+40.8%
FCF MarginFCF ÷ Revenue+1.5%+24.6%-83.5%+59.2%
Rev. Growth (YoY)Latest quarter vs prior year-65.8%+36.7%
EPS Growth (YoY)Latest quarter vs prior year-35.0%-56.7%+104.1%
DAVE leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — CHYM and SOFI and DAVE each lead in 2 of 6 comparable metrics.

At 18.4x trailing earnings, DAVE trades at a 96% valuation discount to AFRM's 449.1x P/E. On an enterprise value basis, SOFI's 22.8x EV/EBITDA is more attractive than AFRM's 210.0x.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …SOFI logoSOFISoFi Technologies…DAVE logoDAVEDave Inc.
Market CapShares × price$7.6B$22.4B$20.4B$3.4B
Enterprise ValueMkt cap + debt − cash$7.3B$28.9B$17.3B$3.3B
Trailing P/EPrice ÷ TTM EPS-7.15x449.07x41.03x18.42x
Forward P/EPrice ÷ next-FY EPS est.112.89x62.49x26.45x19.07x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple209.99x22.75x69.52x
Price / SalesMarket cap ÷ Revenue3.48x6.96x4.28x6.55x
Price / BookPrice ÷ Book value/share32.04x7.48x1.91x10.23x
Price / FCFMarket cap ÷ FCF231.45x37.29x11.57x
Evenly matched — CHYM and SOFI and DAVE each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

DAVE leads this category, winning 6 of 9 comparable metrics.

DAVE delivers a 84.5% return on equity — every $100 of shareholder capital generates $85 in annual profit, vs $-68 for CHYM. CHYM carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to AFRM's 2.56x. On the Piotroski fundamental quality scale (0–9), AFRM scores 6/9 vs SOFI's 3/9, reflecting solid financial health.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …SOFI logoSOFISoFi Technologies…DAVE logoDAVEDave Inc.
ROE (TTM)Return on equity-67.9%+11.2%+5.9%+84.5%
ROA (TTM)Return on assets-49.8%+3.1%+1.1%+49.6%
ROICReturn on invested capital-60.2%-0.7%+3.6%+11.1%
ROCEReturn on capital employed-78.1%-0.9%+1.2%+12.9%
Piotroski ScoreFundamental quality 0–93635
Debt / EquityFinancial leverage0.10x2.56x0.17x0.21x
Net DebtTotal debt minus cash-$332M$6.5B-$3.1B-$5M
Cash & Equiv.Liquid assets$466M$1.4B$4.9B$81M
Total DebtShort + long-term debt$135M$7.9B$1.8B$75M
Interest CoverageEBIT ÷ Interest expense1.88x0.45x22.86x
DAVE leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

DAVE leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in AFRM five years ago would be worth $12,474 today (with dividends reinvested), compared to $5,123 for CHYM. Over the past 12 months, DAVE leads with a +131.2% total return vs CHYM's -48.8%. The 3-year compound annual growth rate (CAGR) favors DAVE at 2.6% vs CHYM's -20.0% — a key indicator of consistent wealth creation.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …SOFI logoSOFISoFi Technologies…DAVE logoDAVEDave Inc.
YTD ReturnYear-to-date-28.0%-9.0%-41.7%+13.6%
1-Year ReturnPast 12 months-48.8%+30.7%+23.0%+131.2%
3-Year ReturnCumulative with dividends-48.8%+464.2%+192.5%+4740.2%
5-Year ReturnCumulative with dividends-48.8%+24.7%-3.1%-20.2%
10-Year ReturnCumulative with dividends-48.8%-30.7%+52.7%-20.5%
CAGR (3Y)Annualised 3-year return-20.0%+78.0%+43.0%+2.6%
DAVE leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CHYM and DAVE each lead in 1 of 2 comparable metrics.

CHYM is the less volatile stock with a 2.50 beta — it tends to amplify market swings less than AFRM's 2.72 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DAVE currently trades 86.6% from its 52-week high vs CHYM's 42.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …SOFI logoSOFISoFi Technologies…DAVE logoDAVEDave Inc.
Beta (5Y)Sensitivity to S&P 5002.50x2.72x2.54x2.69x
52-Week HighHighest price in past year$44.94$100.00$32.73$287.69
52-Week LowLowest price in past year$16.17$42.09$12.56$105.83
% of 52W HighCurrent price vs 52-week peak+42.3%+67.4%+48.9%+86.6%
RSI (14)Momentum oscillator 0–10050.663.141.951.5
Avg Volume (50D)Average daily shares traded4.7M5.3M65.8M607K
Evenly matched — CHYM and DAVE each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: CHYM as "Buy", AFRM as "Buy", SOFI as "Hold", DAVE as "Buy". Consensus price targets imply 39.4% upside for CHYM (target: $27) vs 19.9% for AFRM (target: $81).

MetricCHYM logoCHYMChime Financial, …AFRM logoAFRMAffirm Holdings, …SOFI logoSOFISoFi Technologies…DAVE logoDAVEDave Inc.
Analyst RatingConsensus buy/hold/sellBuyBuyHoldBuy
Price TargetConsensus 12-month target$26.50$80.77$20.89$309.25
# AnalystsCovering analysts8332711
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap+1.0%+1.1%+0.3%+1.3%
Insufficient data to determine a leader in this category.
Key Takeaway

DAVE leads in 3 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 2 categories are tied.

Best OverallDave Inc. (DAVE)Leads 3 of 6 categories
Loading custom metrics...

CHYM vs AFRM vs SOFI vs DAVE: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is CHYM or AFRM or SOFI or DAVE a better buy right now?

For growth investors, Dave Inc.

(DAVE) is the stronger pick with 47. 5% revenue growth year-over-year, versus 28. 8% for SoFi Technologies, Inc. (SOFI). Dave Inc. (DAVE) offers the better valuation at 18. 4x trailing P/E (19. 1x forward), making it the more compelling value choice. Analysts rate Chime Financial, Inc. Class A Common Stock (CHYM) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — CHYM or AFRM or SOFI or DAVE?

On trailing P/E, Dave Inc.

(DAVE) is the cheapest at 18. 4x versus Affirm Holdings, Inc. at 449. 1x. On forward P/E, Dave Inc. is actually cheaper at 19. 1x.

03

Which is the better long-term investment — CHYM or AFRM or SOFI or DAVE?

Over the past 5 years, Affirm Holdings, Inc.

(AFRM) delivered a total return of +24. 7%, compared to -48. 8% for Chime Financial, Inc. Class A Common Stock (CHYM). Over 10 years, the gap is even starker: SOFI returned +52. 7% versus CHYM's -48. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — CHYM or AFRM or SOFI or DAVE?

By beta (market sensitivity over 5 years), Chime Financial, Inc.

Class A Common Stock (CHYM) is the lower-risk stock at 2. 50β versus Affirm Holdings, Inc. 's 2. 72β — meaning AFRM is approximately 9% more volatile than CHYM relative to the S&P 500. On balance sheet safety, Chime Financial, Inc. Class A Common Stock (CHYM) carries a lower debt/equity ratio of 10% versus 3% for Affirm Holdings, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — CHYM or AFRM or SOFI or DAVE?

By revenue growth (latest reported year), Dave Inc.

(DAVE) is pulling ahead at 47. 5% versus 28. 8% for SoFi Technologies, Inc. (SOFI). On earnings-per-share growth, the picture is similar: Dave Inc. grew EPS 222. 9% year-over-year, compared to -37. 2% for Chime Financial, Inc. Class A Common Stock. Over a 3-year CAGR, DAVE leads at 35. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — CHYM or AFRM or SOFI or DAVE?

Dave Inc.

(DAVE) is the more profitable company, earning 38. 3% net margin versus -46. 2% for Chime Financial, Inc. Class A Common Stock — meaning it keeps 38. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SOFI leads at 11. 0% versus -47. 6% for CHYM. At the gross margin level — before operating expenses — CHYM leads at 85. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is CHYM or AFRM or SOFI or DAVE more undervalued right now?

On forward earnings alone, Dave Inc.

(DAVE) trades at 19. 1x forward P/E versus 112. 9x for Chime Financial, Inc. Class A Common Stock — 93. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CHYM: 39. 4% to $26. 50.

08

Which pays a better dividend — CHYM or AFRM or SOFI or DAVE?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is CHYM or AFRM or SOFI or DAVE better for a retirement portfolio?

For long-horizon retirement investors, SoFi Technologies, Inc.

(SOFI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Chime Financial, Inc. Class A Common Stock (CHYM) carries a higher beta of 2. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SOFI: +52. 7%, CHYM: -48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between CHYM and AFRM and SOFI and DAVE?

These companies operate in different sectors (CHYM (Financial Services) and AFRM (Technology) and SOFI (Financial Services) and DAVE (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

CHYM

High-Growth Disruptor

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 15%
  • Gross Margin > 51%
Run This Screen
Stocks Like

AFRM

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Net Margin > 7%
Run This Screen
Stocks Like

SOFI

High-Growth Compounder

  • Sector: Financial Services
  • Market Cap > $100B
  • Revenue Growth > 14%
  • Net Margin > 6%
Run This Screen
Stocks Like

DAVE

High-Growth Quality Leader

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 18%
  • Net Margin > 24%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CHYM and AFRM and SOFI and DAVE on the metrics below

Revenue Growth>
%
(CHYM: 30.7% · AFRM: -65.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.